Bexsero
NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN
Listed by GlaxoSmithKline Biologicals SA
- Strength
- 50 ug/.5mL, 50 ug/.5mL, 50 ug/.5mL, 25 ug/.5mL
- Form
- Injection, Suspension
- Route
- Intramuscular
What it contains
- Neisseria Meningitidis Group B Nhba Fusion Protein Antigen 50 ug/.5mL
- Neisseria Meningitidis Group B Fhbp Fusion Protein Antigen 50 ug/.5mL
- Neisseria Meningitidis Group B Nada Protein Antigen 50 ug/.5mL
- Neisseria Meningitidis Group B Strain Nz98/254 Outer Membrane Vesicle Antigen 25 ug/.5mL
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
FDA record
| Dosage form | Injection, Suspension |
|---|---|
| Route | Intramuscular |
| Approval route | BLA — biologic licence |
| NDC code | 58160-976 |
| FDA application | BLA125546 |
| Package sizes listed | 1 |
| Marketed since | December 2016 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.